April 3rd 2025
The move towards “pharma 4.0” requires a major shift, both ideologically and technologically, to adapt current processes to a framework that will automate much of today’s manufacturing.
Flowsheet Models Modernize Pharmaceutical Manufacturing Design and Risk Assessment
In-silico design facilitates process optimization and evaluation of process control strategies.
Development Progresses in Continuous Solid-Dosage Manufacturing
December 17th 2014FDA funded projects at Rutgers' C-SOPS and at UMass Lowell to develop flow-sheet model algorithms for use in risk assessment, and start-up company Continuus Pharmaceuticals is making progress on their integrated system.